Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study.

<h4>Objective</h4>We evaluated the clinical characteristics of metabolic dysfunction-associated fatty liver disease (MAFLD) to evaluate the usefulness of the MAFLD diagnostic criteria in a resident health survey.<h4>Methods</h4>In 1056 participants of a health survey, we comp...

Full description

Bibliographic Details
Main Authors:	Tetsuyuki Tateda, Chikara Iino, Takafumi Sasada, Satoshi Sato, Go Igarashi, Shogo Kawaguchi, Kenichiro Mikami, Tetsu Endo, Kaori Sawada, Tatsuya Mikami, Shinsaku Fukuda, Shigeyuki Nakaji, Hirotake Sakuraba
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0277930

Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study by Tetsuyuki Tateda, Chikara Iino, Takafumi Sasada, Satoshi Sato, Go Igarashi, Shogo Kawaguchi, Kenichiro Mikami, Tetsu Endo, Kaori Sawada, Tatsuya Mikami, Shinsaku Fukuda, Shigeyuki Nakaji, Hirotake Sakuraba

Published 2022-01-01

Get full text

Article

Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study.

Similar Items